Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Yesterday, May 12, 2015, 114 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $4,322,819.24. Highlighted Stocks Traded by Insiders: Amyris (AMRS) - FREE Research Report Melo John, who is President and CEO at Amyris, sold 65,575 shares at $2.08 on May 12, 2015. Following this transaction, the President and CEO owned 340,942 shares meaning that the stake was reduced by 16.13% with the 65,575-share transaction. The shares most recently traded at $1.99, down $0.09, or 4.53% since the insider transaction. Historical insider transactions for Amyris go as follows:
4-Week # shares sold: 172,186
12-Week # shares sold: 172,186
24-Week # shares sold: 172,186
The average volume for Amyris has been 176,900 shares per day over the past 30 days. Amyris has a market cap of $164.6 million and is part of the basic materials sector and chemicals industry. Shares are unchanged year-to-date as of the close of trading on Tuesday. Amyris, Inc. provides various alternatives to a range of petroleum-sourced products for the consumer care, specialty chemical, and transportation fuel markets worldwide. Currently, there are no analysts who rate Amyris a buy, no analysts rate it a sell, and 2 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on AMRS - FREETheStreet Quant Ratings rates Amyris as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Amyris Ratings Report from TheStreet Quant Ratings now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.